286 related articles for article (PubMed ID: 28218420)
1. Plasma lipoxin A
Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
[TBL] [Abstract][Full Text] [Related]
2. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
[TBL] [Abstract][Full Text] [Related]
3. Folic acid and prevention of colorectal adenomas.
Chae YK; Yun JH
JAMA; 2007 Sep; 298(12):1397; author reply 1397. PubMed ID: 17895454
[No Abstract] [Full Text] [Related]
4. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of leukotriene B4, lipoxin A4, and resolvin D1 plasma levels in pregnant women with risk factors for preeclampsia.
Perucci LO; de Castro Pinto KM; da Silva SPG; Lage EM; Teixeira PG; Barbosa AS; Alpoim PN; de Sousa LP; Talvani A; Dusse LMS
Clin Biochem; 2021 Dec; 98():24-28. PubMed ID: 34492288
[TBL] [Abstract][Full Text] [Related]
6. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
Figueiredo JC; Levine AJ; Grau MV; Midttun O; Ueland PM; Ahnen DJ; Barry EL; Tsang S; Munroe D; Ali I; Haile RW; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2136-45. PubMed ID: 18708408
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
8. Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
Gao QY; Chen HM; Chen YX; Wang YC; Wang ZH; Tang JT; Ge ZZ; Chen XY; Sheng JQ; Fang DC; Yu CG; Zheng P; Fang JY
Cancer Prev Res (Phila); 2013 Jul; 6(7):744-52. PubMed ID: 23682073
[TBL] [Abstract][Full Text] [Related]
9. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
[TBL] [Abstract][Full Text] [Related]
10. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.
Goicoechea M; Sanchez-Niño MD; Ortiz A; García de Vinuesa S; Quiroga B; Bernis C; Morales E; Fernández-Juarez G; de Sequera P; Verdalles U; Verde E; Luño J
Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():8-13. PubMed ID: 28987723
[TBL] [Abstract][Full Text] [Related]
11. 15-Epi-LXA
Sekheri M; El Kebir D; Edner N; Filep JG
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
[TBL] [Abstract][Full Text] [Related]
13. Low LXA4, RvD1 and RvE1 levels may be an indicator of the development of hypertension.
Yücel H; Özdemir AT
Prostaglandins Leukot Essent Fatty Acids; 2021 Nov; 174():102365. PubMed ID: 34740030
[TBL] [Abstract][Full Text] [Related]
14. Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.
Levine AJ; Grau MV; Mott LA; Ueland PM; Baron JA
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2541-8. PubMed ID: 20841390
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
16. Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk.
Rees JR; Morris CB; Peacock JL; Ueland PM; Barry EL; McKeown-Eyssen GE; Figueiredo JC; Snover DC; Baron JA
Cancer Prev Res (Phila); 2017 Aug; 10(8):451-458. PubMed ID: 28600398
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of aspirin to prevent colorectal adenomas.
Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
20. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
